Observational Study of Interstitial Lung Disease (ILD)
This is an observational study looking at the natural progression of Interstitial Lung Diseases (ILD), which are a group of conditions causing scarring of the lungs. This study aims to understand how these diseases, including Idiopathic Pulmonary Fibrosis and Sarcoidosis, develop over time. Researchers will collect data and blood samples from people with ILD, as well as from a control group without ILD, to better describe the characteristics of these diseases. The main goal is to track the natural course of ILD yearly. You may be able to join if you are 18 years or older and have an Interstitial Lung Disease. The study plans to enroll 4000 participants.
- Study design
- This is an observational study, meaning no specific treatments are being tested. It plans to include 4000 participants.
- What's involved
- Researchers will acquire data and blood samples from participants. This will happen yearly.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed yearly to track the natural history of their disease.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Mary E Strek, MD · PRINCIPAL_INVESTIGATOR · University of Chicago
Who to contact
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Natural history of course of disease in patients with Interstitial lung disease (ILD)Yearly
We assess mortality roughly yearly but duration is unlimited